Education
About Us
Working with TipRanks
Follow Us
OncoTherapy Science, Inc. (DE:30O)
:30O
| Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 750.05M | ¥ 610.12M | ¥ 1.13B | ¥ 1.15B | ¥ 332.48M |
| Gross Profit | ¥ -12.76M | ¥ -177.72M | ¥ 41.69M | ¥ 113.91M | ¥ 19.54M |
| Operating Income | ¥ -797.94M | ¥ -1.12B | ¥ -1.11B | ¥ -2.05B | ¥ -1.64B |
| EBITDA | ¥ -811.92M | ¥ -1.29B | ¥ -1.09B | ¥ -2.04B | ¥ -1.59B |
| Net Income | ¥ -815.28M | ¥ -1.29B | ¥ -1.12B | ¥ -2.57B | ¥ -1.56B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 833.88M | ¥ 527.66M | ¥ 1.12B | ¥ 1.84B | ¥ 2.90B |
| Total Assets | ¥ 1.16B | ¥ 867.27M | ¥ 1.51B | ¥ 2.69B | ¥ 3.37B |
| Total Debt | ¥ 51.07M | ¥ 106.85M | ¥ 0.00 | ¥ 0.00 | ¥ 0.00 |
| Net Debt | ¥ -782.82M | ¥ -420.81M | ¥ -1.12B | ¥ -1.84B | ¥ -2.90B |
| Total Liabilities | ¥ 426.09M | ¥ 513.61M | ¥ 656.27M | ¥ 704.97M | ¥ 291.28M |
| Stockholders' Equity | ¥ 729.11M | ¥ 353.67M | ¥ 855.17M | ¥ 1.98B | ¥ 3.08B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -815.30M | ¥ -1.23B | ¥ -800.29M | ¥ -2.53B | ¥ -1.81B |
| Operating Cash Flow | ¥ -815.02M | ¥ -1.23B | ¥ -794.90M | ¥ -2.07B | ¥ -1.76B |
| Investing Cash Flow | ¥ -279.00K | ¥ -33.35M | ¥ -20.32M | ¥ -467.93M | ¥ -52.23M |
| Financing Cash Flow | ¥ 1.12B | ¥ 671.37M | ¥ 95.95M | ¥ 1.48B | ¥ 0.00 |